维普中文期刊产品整合服务
18篇 您的检索式:作者名="FASOLA G"
    题名 作者 年代 出处 被引量
1Targeting the VEGF path- way: Antiangiogenic strategies in the treatment of non - small cell lung cancer显示文摘Aita M Fasola G Defferrari C 2008Critical Reviews Oncol Hemato12008,68,3:1
2Hepatitis C and mycophenolate mofetil-a clarification显示文摘Fasola Carlos G Klintmalm Goran B 2002Liver-Transpl2002,8,:1
3Prospects for hepatocyte transplantation显示文摘BUMGARDNER G L FASOLA C SUTHERLAND D E 1988Hepatology1988,8,5:1
4Targeting the VEGF pathway : antiangiogenic strategies in the treatment of non-small cell lung cancer显示文摘Aita M Fasola G Defferrari C 2008Crit Rev Oncol Hematol2008,68,3:1
5Hepatitis C and mycophenolate mofetil-a clarification显示文摘Fasola Carlos G Klintmalm Goran B 2002Liver Transpl2002,8,4:1
6Diagnosis and treatment of cytomegalovirus disease in translant patients based on gastrointestinal tract manifestations 显示文摘MAYORAL J L LOEFFLER C M FASOLA C G 2012Archives of Surgery2012,13,6:1
7Prospectsfor hepatocyte transplantation 显示文摘Bumgardner G L Fasola C Sutherland D E 1988Hepatology1988,8,5:1
8Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer显示文摘Aita M Fasola G Defferrari C 2008Crit Rev Oncol Hematol2008,68,3:1
9Targeting the VEGF pathway:antiangiogenic strategies in the treatment of non-small cell lung cancer显示文摘Aita M Fasola G Defferrari C 2008Crit Rev Oncol Hematol2008,68,3:1
10Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population:baseline results of a prospective ,nonrandomized feasibility trial-an Alpe-adria Thoracic Oncology Muhidisciplinary Group Study(ATOM 002) 显示文摘Fasola G Belvedere O Aita M 2007Oncologist2007,12,10:1
11Highlights from the 42nd annual meeting of the American Society of Clinical Oncology 显示文摘Puglisi F Andreetta C Fasola G 2006Expert Opinion On Pharmacotherapy2006,7,16:1
12Tar geting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer显示文摘AITA M FASOLA G DEFFERRARI C 2008Crit Rev Oncol Hematol2008,68,:1
13KRAS/NRAS mutations in PEAK: a randomized phase 2 study of lst-line treatment with FOLFOX6 + panitumumab or bevacizumabfor wild-type KRAS mCRC 显示文摘Rivera F Karthaus M Fasola G 2013Ann Oncol2013,24,4:1
14Pegylated lipo- somal doxorubicin in elderly patients with metastatic breast cancer显示文摘Minisini AM Andreetta C Fasola G 2008Expert Rev Anticancer Ther2008,8,3:1
15Experience with ulcerated, bleeding autologous dialysis fistulas显示文摘Jaffers G J Fasola C G 2012J Vasc Access2012,13,1:1
16Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy显示文摘F Donato A Tagger R Chiesa ML Ribero V Tomasoni M Fasola U Gelatti G Portera P Boffetta G Nardi 1997Hepatology1997,,3:1
17Trends of organochlorine residues in eggs of birds from Italy, 1977 to 1985 显示文摘Fasola M Vecchio L Caccialanza G 1957Environmental Pollution1957,45,1:1
18Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer 显示文摘Aita M Fasola G Defferrari C 2008Crit Rev Oncol Hematol2008,68,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费